92 related articles for article (PubMed ID: 11300494)
1. Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients.
Schmielau J; Nalesnik MA; Finn OJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):933s-939s. PubMed ID: 11300494
[TBL] [Abstract][Full Text] [Related]
2. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
[TBL] [Abstract][Full Text] [Related]
3. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.
Schmielau J; Finn OJ
Cancer Res; 2001 Jun; 61(12):4756-60. PubMed ID: 11406548
[TBL] [Abstract][Full Text] [Related]
4. Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer.
Takahashi A; Kono K; Amemiya H; Iizuka H; Fujii H; Matsumoto Y
Clin Cancer Res; 2001 Jan; 7(1):74-80. PubMed ID: 11205921
[TBL] [Abstract][Full Text] [Related]
5. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.
Liossis SN; Ding XZ; Dennis GJ; Tsokos GC
J Clin Invest; 1998 Apr; 101(7):1448-57. PubMed ID: 9525988
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
[TBL] [Abstract][Full Text] [Related]
7. Lactoferrin-induced up-regulation of zeta (zeta) chain expression in peripheral blood T lymphocytes from cervical cancer patients.
Frydecka I; Zimecki M; Bocko D; Kosmaczewska A; Teodorowska R; Ciszak L; Kruzel M; Wlodarska-Polinsk J; Kuliczkowski K; Kornafel J
Anticancer Res; 2002; 22(3):1897-901. PubMed ID: 12168890
[TBL] [Abstract][Full Text] [Related]
8. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
Dworacki G; Meidenbauer N; Kuss I; Hoffmann TK; Gooding W; Lotze M; Whiteside TL
Clin Cancer Res; 2001 Mar; 7(3 Suppl):947s-957s. PubMed ID: 11300496
[TBL] [Abstract][Full Text] [Related]
9. [Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results].
Musiał K; Ciszak L; Kosmaczewska A; Szteblich A; Pawlak E; Zwolińska D; Frydecka I
Przegl Lek; 2006; 63 Suppl 3():208-10. PubMed ID: 16898532
[TBL] [Abstract][Full Text] [Related]
10. Intracellular cytokine analysis of interferon-gamma in T cells of patients with chronic myeloid leukemia.
Aswald JM; Lipton JH; Messner HA
Cytokines Cell Mol Ther; 2002 Dec; 7(2):75-82. PubMed ID: 12607798
[TBL] [Abstract][Full Text] [Related]
11. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
12. Absent or low expression of T-cell receptor zeta-chain in T cells infiltrating human pathological skin conditions.
Alaibac M; Pigozzi B; Saponeri A; Belloni-Fortina A; Peserico A
Arch Dermatol Res; 2002 Nov; 294(8):380-2. PubMed ID: 12420108
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.
Kono K; Ressing ME; Brandt RM; Melief CJ; Potkul RK; Andersson B; Petersson M; Kast WM; Kiessling R
Clin Cancer Res; 1996 Nov; 2(11):1825-8. PubMed ID: 9816136
[TBL] [Abstract][Full Text] [Related]
14. TCR zeta-chain abnormalities in human systemic lupus erythematosus.
Nambiar MP; Krishnan S; Warke VG; Tsokos GC
Methods Mol Med; 2004; 102():49-72. PubMed ID: 15286380
[TBL] [Abstract][Full Text] [Related]
15. Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma.
Lockhart DC; Chan AK; Mak S; Joo HG; Daust HA; Carritte A; Douville CC; Goedegebuure PS; Eberlein TJ
Surgery; 2001 Jun; 129(6):749-56. PubMed ID: 11391375
[TBL] [Abstract][Full Text] [Related]
16. Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs in mediating modulation of T cell function.
Bao JY; Huang Y; Wang F; Peng YP; Qiu YH
Neuroimmunomodulation; 2007; 14(6):344-53. PubMed ID: 18463421
[TBL] [Abstract][Full Text] [Related]
17. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
[TBL] [Abstract][Full Text] [Related]
18. Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients.
Taylor DD; Bender DP; Gerçel-Taylor C ; Stanson J; Whiteside TL
Br J Cancer; 2001 Jun; 84(12):1624-9. PubMed ID: 11401315
[TBL] [Abstract][Full Text] [Related]
19. (5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling.
Zhou R; Wang JX; Tang W; He PL; Yang YF; Li YC; Li XY; Zuo JP
Acta Pharmacol Sin; 2006 Dec; 27(12):1616-21. PubMed ID: 17112417
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
